Kronos Advanced Technologies Inc. (OTCMKTS:KNOS) Stock Sees Selling Pressure At Higher Level

Kronos Advanced Technologies Inc. (OTCMKTS:KNOS) fell 5% after announcing that its subsidiary Zyppah Inc. which focuses on improving sleep health, has announced the return of several saving events for “Black Friday.”

Market Reaction

On Monday, KNOS stock fell 5% to $0.0358 with more than 391k shares, compared to its average volume of 826k shares. The stock has moved within a range of $0.0355 – 0.0383 after opening the trade at $0.0383.

Subsidiary Zyppah Inc Announces Early Return Of 2021 Black Friday Deals

Following encouraging customer response for Zyppah’s Black Friday experience in the past, the subsidiary is at it again.Zyppah provides a snoring solution through a proprietary tongue guard and a Sleep Certified dentists network that help individuals suffering from obstructive sleep apnea or those who snore.

Zyppah CEO and founder Jonathan Greenburg stated that snoring is a serious issue that is often overlooked and currently affects around 90 million Americans. Greenburg said that chronic snoring results in various conditions ranging from diabetes to high blood pressure. The company has the number one commercialized anti-snoring device that has FDA Clarence and can be purchased over the counter. In 2019, the company received FDA registration #K18212 for the device. Therefore, in the coming weeks, investors should keep an eye on KNOS.

Key Quote

“While often overlooked or thought of as funny, snoring is a serious problem that affects approximately 90 million Americans. Chronic snoring can lead to a variety of ailments from high blood pressure to diabetes,” said Dr. Jonathan Greenburg, CEO, and Founder of ZYPPAH®.

Traders Review

KNOS stock is trading below the 200-Day and 50-Day Moving averages of $0.0370 and $0.0370 respectively. However, the stock is trading below the 200-Day moving average of $0.0639. The stock is down 9% over the past month.


Leave a Reply

Your email address will not be published.